Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation
Atrial fibrillation (AF) is the most common supraventricular arrhythmia in the population. MicroRNAs (small endogenous noncoding RNAs) are attractive candidates as biomarkers for AF, especially considering that miRNAs are stable and are detected within easily accessible biofluids such as blood. In t...
Main Authors: | Ananília Medeiros Gomes da Silva, Jéssica Nayara Góes de Araújo, Renata Caroline Costa de Freitas, Vivian Nogueira Silbiger |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/7804763 |
Similar Items
-
Atrial Fibrillation and MicroRNAs
by: Gaetano eSantulli, et al.
Published: (2014-01-01) -
MicroRNAs in Atrial Fibrillation: Pathophysiological Aspects and Potential Biomarkers
by: Aleksey M. Chaulin, et al.
Published: (2020-09-01) -
The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
by: Xiaona Xu, et al.
Published: (2020-01-01) -
Circulating MicroRNAs as Biomarkers for Sepsis
by: Fabian Benz, et al.
Published: (2016-01-01) -
Circulating MicroRNAs: Potential Biomarkers for Cancer
by: Yi-Tao Ding, et al.
Published: (2011-03-01)